ResearcherMimetas (Netherlands)No recent work listed
Marlene Geyer
Matched on ORCID iD 0000-0003-4095-3298; OpenAlex author ID A5001717307. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: none · 2023: 2 papers
Papers 3
- A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment. Co-author DOI 10.1038/s41420-023-01334-z↗
- The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model. Co-author DOI 10.3389/fimmu.2023.1155085↗
- Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening. Co-author DOI 10.3389/fcell.2021.761807↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Karla C. S. Queiroz · 3 shared papers, 2021–2023 · strength 0.74
- Paper Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening. DOI 10.3389/fcell.2021.761807↗
- Paper The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model. DOI 10.3389/fimmu.2023.1155085↗
- Paper A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment. DOI 10.1038/s41420-023-01334-z↗
- Vincenzo Corbo · 1 shared paper, 2023 · strength 0.24
- Sabrina L. D’Agosto · 1 shared paper, 2023 · strength 0.24
- Daniel Schreyer · 1 shared paper, 2023 · strength 0.22
- Christian P. Pilarsky · 1 shared paper, 2023 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.